A detailed history of Csenge Advisory Group transactions in Zoetis Inc. stock. As of the latest transaction made, Csenge Advisory Group holds 5,233 shares of ZTS stock, worth $861,875. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,233
Previous 5,700 8.19%
Holding current value
$861,875
Previous $988,000 3.44%
% of portfolio
0.05%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$172.58 - $196.48 $80,594 - $91,756
-467 Reduced 8.19%
5,233 $1.02 Million
Q2 2024

Jul 10, 2024

BUY
$145.54 - $178.83 $10,333 - $12,696
71 Added 1.26%
5,700 $988,000
Q1 2024

May 03, 2024

SELL
$165.67 - $199.94 $165 - $199
-1 Reduced 0.02%
5,629 $952,000
Q4 2023

Feb 13, 2024

BUY
$151.44 - $200.09 $35,739 - $47,221
236 Added 4.38%
5,630 $1.11 Million
Q3 2023

Nov 01, 2023

BUY
$167.14 - $192.77 $120,340 - $138,794
720 Added 15.4%
5,394 $938,000
Q2 2023

Jul 20, 2023

SELL
$160.94 - $186.23 $17,542 - $20,299
-109 Reduced 2.28%
4,674 $804,000
Q1 2023

May 01, 2023

BUY
$145.48 - $175.02 $14,547 - $17,502
100 Added 2.14%
4,783 $796,000
Q4 2022

Feb 10, 2023

SELL
$131.14 - $157.47 $36,719 - $44,091
-280 Reduced 5.64%
4,683 $686,000
Q3 2022

Oct 04, 2022

BUY
$148.29 - $182.55 $9,490 - $11,683
64 Added 1.31%
4,963 $736,000
Q2 2022

Jul 27, 2022

SELL
$155.97 - $200.09 $29,634 - $38,017
-190 Reduced 3.73%
4,899 $842,000
Q1 2022

May 09, 2022

SELL
$181.39 - $234.03 $38,273 - $49,380
-211 Reduced 3.98%
5,089 $960,000
Q4 2021

Feb 10, 2022

SELL
$193.69 - $247.03 $6,779 - $8,646
-35 Reduced 0.66%
5,300 $1 Million
Q3 2021

Oct 20, 2021

BUY
$189.29 - $209.69 $6,625 - $7,339
35 Added 0.66%
5,335 $1.05 Million
Q2 2021

Jul 21, 2021

BUY
$155.9 - $187.99 $470,350 - $567,165
3,017 Added 132.15%
5,300 $1 Million
Q1 2021

Apr 28, 2021

SELL
$144.0 - $169.39 $730,800 - $859,654
-5,075 Reduced 68.97%
2,283 $365,000
Q4 2020

Jan 26, 2021

SELL
$157.07 - $174.35 $26,701 - $29,639
-170 Reduced 2.26%
7,358 $1.22 Million
Q3 2020

Nov 09, 2020

SELL
$137.1 - $165.37 $42,501 - $51,264
-310 Reduced 3.96%
7,528 $1.22 Million
Q2 2020

Jul 17, 2020

SELL
$111.92 - $142.53 $17,795 - $22,662
-159 Reduced 1.99%
7,838 $1.07 Million
Q1 2020

Apr 21, 2020

BUY
$92.66 - $144.94 $41,419 - $64,788
447 Added 5.92%
7,997 $941,000
Q4 2019

Feb 05, 2020

SELL
$116.25 - $133.25 $11,973 - $13,724
-103 Reduced 1.35%
7,550 $999,000
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $139,924 - $159,638
1,243 Added 19.39%
7,653 $953,000
Q2 2019

Jul 30, 2019

SELL
$97.98 - $114.28 $220,748 - $257,472
-2,253 Reduced 26.01%
6,410 $727,000
Q1 2019

May 07, 2019

BUY
$81.56 - $100.67 $52,443 - $64,730
643 Added 8.02%
8,663 $872,000
Q4 2018

Feb 07, 2019

BUY
$79.28 - $95.27 $417,092 - $501,215
5,261 Added 190.69%
8,020 $686,000
Q3 2018

Nov 19, 2018

BUY
$83.5 - $93.23 $584 - $652
7 Added 0.25%
2,759 $255,000
Q2 2018

Aug 10, 2018

BUY
$79.9 - $89.2 $28,124 - $31,398
352 Added 14.67%
2,752 $238,000
Q1 2018

May 10, 2018

BUY
$71.51 - $84.69 $171,624 - $203,256
2,400 New
2,400 $200,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Csenge Advisory Group Portfolio

Follow Csenge Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.